Ticker Scorecard - RAPP Basics Company: Rapport Therapeutics, Inc. Common Stock IPO Date: June 7, 2024 Sector: Healthcare Industry: Biotech Market Cap: $463.79M Activated in VL: True Average Daily Range Avg Daily Range: $0.98 | 4.62% Avg Daily Range (30 D): $0.62 | 4.08% Avg Daily Range (90 D): $0.81 | 3.99% Institutional Daily Volume Avg Daily Volume: .11M Avg Daily Volume (30 D): .08M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 55 Avg Trade Size (Sh.) (30 D): 44 Avg Trade Size (Sh.) (90 D): 42 Institutional Trades Total Inst.Trades: 35 Avg Inst. Trade: $2.28M Avg Inst. Trade (30 D): $1.04M Avg Inst. Trade (90 D): $2.04M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.98M Avg Closing Trade (30 D): $4.96M Avg Closing Trade (90 D): $2.95M Avg Closing Volume: 189.17K     News Jan 9, 2025 @ 12:00 PM Rapport Therapeutics Announces New Phase 1 Data, F... Source: N/A Sep 5, 2024 @ 11:00 AM Rapport Therapeutics to Present at Upcoming Epilep... Source: N/A Aug 29, 2024 @ 11:00 AM Rapport Therapeutics to Present at 22nd Annual Mor... Source: N/A Jun 30, 2024 @ 1:10 PM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Jun 12, 2024 @ 8:01 PM Rapport Therapeutics Announces Closing of $174 Mil... Source: Rapport Therapeutics, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.5 $-1.7 Diluted EPS $-.5 $-1.7 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ -71.86M $ -17.54M $ -18.12M Operating Income / Loss $ $ -21.64M $ -20.8M Cost of Revenue $ $ $ Net Cash Flow $ $ -70.85M $ PE Ratio